Finance

Beta
Lists
CBIO:NASDAQ
Crescent Biopharma Inc
$17.95
-1.32%
(-0.24) 1D
$17.95
0.00% (0.00)
After hours
Closed: Jun 16, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CBIO...
Open
$18.15
High
$18.20
Low
$17.14
Mkt. cap
494.92M
Avg. vol.
264.49K
Volume
124.16K
52-wk high
$27.41
52-wk low
$8.72
EPS
-$12.25
Beta
1.16
Shares outstanding
27.57M
No. of employees
55
Open
$18.15
High
$18.20
Low
$17.14
Mkt. cap
494.92M
Avg. vol.
264.49K
Volume
124.16K
52-wk high
$27.41
52-wk low
$8.72
EPS
-$12.25
Beta
1.16
Shares outstanding
27.57M
No. of employees
55
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to CBIO in the past 3 months
Strong Buy
Buy
6
Hold
1
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CBIO in the last 3 months.
Highest
Current $17.95
$35.00 (+94.99%)
Average
$31.00 (+72.70%)
Lowest
$27.00 (+50.42%)
News stories
From sources across the web
About Crescent Biopharma Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
10.84M
1.04M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.08M
20.35M
95.03M
17.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.95M
5.54M
7.31M
7.86M
Operating expense
21.03M
25.88M
102.34M
25.77M
Total operating expenses
21.03M
25.88M
102.34M
25.77M
Operating income
-21.03M
-25.88M
-91.49M
-24.73M
Other non operating income
-
-
-
-
EBT including unusual items
-21.79M
-24.61M
-90.40M
-23.28M
EBT excluding unusual items
-21.79M
-24.61M
-90.40M
-23.28M
Income tax expense
-
-
2.00M
-
Effective tax rate
-
-
-2.21%
-
Other operating expenses
-
-
-
-
Net income
-21.79M
-24.61M
-92.40M
-23.28M
Net profit margin
-
-
-852.06%
-2,240.90%
Earnings per share
-3.72
-1.37
-4.92
-0.70
Interest and investment income
313.00K
1.28M
1.10M
1.45M
Interest expense
-1.07M
-
-
-
Net interest expenses
-760.00K
1.28M
1.10M
1.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.03M
-25.86M
-91.44M
-24.66M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more